EMA accepts Arvelle’s cenobamate MAA
There are about six million people in Europe with epilepsy, and approximately 40% of adults with focal-onset seizures continue to experience seizures.
Read More
Author: Anna Smith
COVID-19: ‘Army’ of volunteers join NHS as BMS postpones new study starts
The FDA has also granted Gilead’s wishes to withdraw orphan drug designation for remdesivir under current circumstances.
Read More
Astellas, CytomX form T-cell engaging cancer antibodies partnership
Astellas has confirmed that it will make an upfront cash payment of $80 million to CytomX.
Read More
Novavax plans FDA filing after NanoFlu trumps Sanofi flu vaccine
The vaccine met all primary endpoints in adults aged 65 and older against Sanofi’s Fluzone Quadrivalent.
Read More
Botox gets license update in UK
Previously the licence referred to “physicians”, prompting confusion over who is able to inject the treatment.
Read More- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
